Literature DB >> 1381364

Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver.

T Deguchi1.   

Abstract

Fifty human livers obtained at autopsy were analyzed for N-acetyltransferase and classified into six genotypes. Determination of N-acetyltransferase activity and proteins from supernatants of liver homogenates indicate that genotype I corresponds to rapid acetylator, genotypes II and III to intermediate acetylator, and genotypes IV, V, and VI to slow acetylator phenotypes. Northern blot analysis shows that levels of mRNA for N-acetyltransferase in the livers do not markedly differ among the six genotypes. Three alleles of the N-acetyltransferase gene were cloned and sequenced. mRNA is coded in two exons. Comparison of alleles 2 and 3, which correspond to low N-acetyltransferase activity, with allele 1, which corresponds to high N-acetyltransferase activity, revealed several polymorphisms. Two gene sequence differences occur in the coding exons of alleles 2 and 3, one of which would produce different amino acids in the proteins. Those sequence differences that lead to amino acid substitutions result in a loss of BamHI and TaqI sites for alleles 2 and 3, respectively. Expression studies of the alleles in Chinese hamster ovary cells show that allele 1 expresses high levels of N-acetyltransferase activity and enzyme protein, while alleles 2 and 3 express low levels of both protein and activity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381364

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  A meta-analysis of the NAT1 and NAT2 polymorphisms and prostate cancer: a huge review.

Authors:  Chunming Gong; Xueying Hu; Yong Gao; Yunfei Cao; Feng Gao; Zengnan Mo
Journal:  Med Oncol       Date:  2010-01-23       Impact factor: 3.064

2.  Codominant expression of N-acetylation and O-acetylation activities catalyzed by N-acetyltransferase 2 in human hepatocytes.

Authors:  Mark A Doll; Yu Zang; Timothy Moeller; David W Hein
Journal:  J Pharmacol Exp Ther       Date:  2010-04-29       Impact factor: 4.030

3.  Chromosomal localization of human genes for arylamine N-acetyltransferase.

Authors:  D Hickman; A Risch; V Buckle; N K Spurr; S J Jeremiah; A McCarthy; E Sim
Journal:  Biochem J       Date:  1994-02-01       Impact factor: 3.857

4.  Smoking, the xenobiotic pathway, and clubfoot.

Authors:  Amy Sommer; Susan H Blanton; Katelyn Weymouth; Christine Alvarez; B Stephen Richards; Douglas Barnes; Jacqueline T Hecht
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-12-01

5.  Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases.

Authors:  D W Hein; T D Rustan; R J Ferguson; M A Doll; K Gray
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

6.  Identification of N-acetyltransferase 2 (NAT2) transcription start sites and quantitation of NAT2-specific mRNA in human tissues.

Authors:  Anwar Husain; Xiaoyan Zhang; Mark A Doll; J Christopher States; David F Barker; David W Hein
Journal:  Drug Metab Dispos       Date:  2007-02-07       Impact factor: 3.922

7.  Arylamine N-acetyltransferase activity in human cultured cell lines.

Authors:  E Coroneos; E Sim
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

Review 8.  Structure/function evaluations of single nucleotide polymorphisms in human N-acetyltransferase 2.

Authors:  Jason M Walraven; Yu Zang; John O Trent; David W Hein
Journal:  Curr Drug Metab       Date:  2008-07       Impact factor: 3.731

Review 9.  N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk.

Authors:  D W Hein
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

10.  Human acetylator genotype: relationship to colorectal cancer incidence and arylamine N-acetyltransferase expression in colon cytosol.

Authors:  J W Rodriguez; W G Kirlin; R J Ferguson; M A Doll; K Gray; T D Rustan; M E Lee; K Kemp; P Urso; D W Hein
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.